Felix Geissler, M.D. Ph.D.

Vice President of Medical Affairs

Dr. Geissler is Vice President of Medical Affairs at Curis. Dr. Geissler is a board-certified surgeon and immunologist with twenty years of experience  in global medical affairs and clinical research. At Horizon Therapeutics, he served as Vice President, Medical Affairs, and led and directed the development and execution of the Medical Affairs strategy and operations for their comprehensive marketed product portfolio and investigational products across rare and ultra-rare disease indications. Previously, Dr. Geissler served as Chief Medical Officer at Lumicell. Earlier, he served as Sanofi’s Vice President & Medical Head of Oncology, Hematology, and Transplant. Dr. Geissler began his career in industry at Bristol-Myers Squibb and Novartis. Dr. Geissler received his M.D. from the University of Innsbruck (Austria)/University of Munich (Germany) and his Ph.D. from the University of Tuebingen (Germany). His post-doctoral scientific research was conducted in transplant immunology at the University of Wisconsin in Madison.